GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytori Cell Research Institute Inc (TSE:3750) » Definitions » Shiller PE Ratio

Cytori Cell Research Institute (TSE:3750) Shiller PE Ratio : (As of Jun. 10, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Cytori Cell Research Institute Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Cytori Cell Research Institute Shiller PE Ratio Historical Data

The historical data trend for Cytori Cell Research Institute's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytori Cell Research Institute Shiller PE Ratio Chart

Cytori Cell Research Institute Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 24.74 264.94 116.59 -

Cytori Cell Research Institute Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 518.55 - - - -

Competitive Comparison of Cytori Cell Research Institute's Shiller PE Ratio

For the Biotechnology subindustry, Cytori Cell Research Institute's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cytori Cell Research Institute's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cytori Cell Research Institute's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Cytori Cell Research Institute's Shiller PE Ratio falls into.



Cytori Cell Research Institute Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Cytori Cell Research Institute's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Cytori Cell Research Institute's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-12.25/106.8000*106.8000
=-12.250

Current CPI (Dec. 2023) = 106.8000.

Cytori Cell Research Institute Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 30.005 95.700 33.485
201406 -3.246 98.000 -3.537
201409 -3.350 98.500 -3.632
201412 13.352 97.900 14.566
201503 10.056 97.900 10.970
201506 43.920 98.400 47.669
201509 -1.722 98.500 -1.867
201512 0.809 98.100 0.881
201603 -38.275 97.900 -41.755
201606 -27.686 98.100 -30.141
201609 -2.294 98.000 -2.500
201612 -3.482 98.400 -3.779
201703 -59.142 98.100 -64.387
201706 -9.550 98.500 -10.355
201709 -2.490 98.800 -2.692
201712 24.130 99.400 25.926
201803 54.160 99.200 58.309
201806 44.710 99.200 48.135
201809 -18.280 99.900 -19.543
201812 6.690 99.700 7.166
201903 55.176 99.700 59.105
201906 4.260 99.800 4.559
201909 -0.610 100.100 -0.651
201912 -8.186 100.500 -8.699
202003 52.110 100.300 55.487
202006 4.620 99.900 4.939
202009 -20.190 99.900 -21.585
202012 -5.131 99.300 -5.519
202103 -81.450 99.900 -87.076
202106 -10.690 99.500 -11.474
202109 6.710 100.100 7.159
202112 10.767 100.100 11.488
202203 -15.760 101.100 -16.649
202206 -32.210 101.800 -33.792
202209 -30.657 103.100 -31.757
202212 -18.090 104.100 -18.559
202303 -37.760 104.400 -38.628
202306 -18.070 105.200 -18.345
202309 -31.589 106.200 -31.767
202312 -12.250 106.800 -12.250

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cytori Cell Research Institute  (TSE:3750) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Cytori Cell Research Institute Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Cytori Cell Research Institute's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cytori Cell Research Institute (TSE:3750) Business Description

Traded in Other Exchanges
N/A
Address
1-1-1 Otemachi, Otemachi Park Building, Chiyoda-ku, Tokyo, JPN, 100-0004
Cytori Cell Research Institute Inc developing a new clinical approach to cell therapy to provide better medical care to patients by providing medical care that responds to unmet medical needs based on innovative regenerative medicine. Its product pipeline includes Habeo; ECCO-50 and others.

Cytori Cell Research Institute (TSE:3750) Headlines

No Headlines